Elin Electronics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 13, 2025, 8:28 am

Quick Insight

Elin Electronics Ltd, operating in the consumer electronics sector, currently trades at a price of 229 with a market capitalization of 1,138 Cr. The company's P/E ratio stands at 34.7, indicating a premium valuation relative to earnings. With a ROE of 4.38% and ROCE at 6.97%, it suggests a moderate return on equity and capital employed. Elin's OPM is at 5.94%, highlighting a challenge in operational efficiency. The company's low net profit of 29 Cr raises concerns about profitability. While the promoter holding is strong at 32.98%, institutional ownership is relatively low. With a healthy ICR of 9.32x, Elin Electronics faces a liquidity position. In conclusion, Elin Electronics Ltd shows potential for improvement in operational performance and profitability, but investors should carefully monitor its financial metrics for sustained growth.

Competitors of Elin Electronics Ltd

All Competitor Stocks of Elin Electronics Ltd

Quarterly Result

Last Updated: August 19, 2025, 3:48 pm

Below is a detailed analysis of the quarterly data for Elin Electronics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 295.48 Cr.. The value appears to be declining and may need further review. It has decreased from 315.75 Cr. (Mar 2025) to 295.48 Cr., marking a decrease of 20.27 Cr..
• For Expenses, as of Jun 2025, the value is 277.92 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 295.50 Cr. (Mar 2025) to 277.92 Cr., marking a decrease of 17.58 Cr..
• For Operating Profit, as of Jun 2025, the value is 17.56 Cr.. The value appears to be declining and may need further review. It has decreased from 20.25 Cr. (Mar 2025) to 17.56 Cr., marking a decrease of 2.69 Cr..
• For OPM %, as of Jun 2025, the value is 5.94%. The value appears to be declining and may need further review. It has decreased from 6.41% (Mar 2025) to 5.94%, marking a decrease of 0.47%.
• For Other Income, as of Jun 2025, the value is 2.99 Cr.. The value appears to be declining and may need further review. It has decreased from 11.24 Cr. (Mar 2025) to 2.99 Cr., marking a decrease of 8.25 Cr..
• For Interest, as of Jun 2025, the value is 2.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.11 Cr. (Mar 2025) to 2.02 Cr., marking a decrease of 0.09 Cr..
• For Depreciation, as of Jun 2025, the value is 5.86 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.36 Cr. (Mar 2025) to 5.86 Cr., marking a decrease of 1.50 Cr..
• For Profit before tax, as of Jun 2025, the value is 12.67 Cr.. The value appears to be declining and may need further review. It has decreased from 22.02 Cr. (Mar 2025) to 12.67 Cr., marking a decrease of 9.35 Cr..
• For Tax %, as of Jun 2025, the value is 25.89%. The value appears to be increasing, which may not be favorable. It has increased from 21.80% (Mar 2025) to 25.89%, marking an increase of 4.09%.
• For Net Profit, as of Jun 2025, the value is 9.39 Cr.. The value appears to be declining and may need further review. It has decreased from 17.22 Cr. (Mar 2025) to 9.39 Cr., marking a decrease of 7.83 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.89. The value appears to be declining and may need further review. It has decreased from 3.47 (Mar 2025) to 1.89, marking a decrease of 1.58.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:37 pm

Growth

Last Updated: September 5, 2025, 3:21 pm

Balance Sheet

Last Updated: July 25, 2025, 1:22 pm

Below is a detailed analysis of the balance sheet data for Elin Electronics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 24.00 Cr..
• For Reserves, as of Mar 2025, the value is 510.00 Cr.. The value appears strong and on an upward trend. It has increased from 479.00 Cr. (Mar 2024) to 510.00 Cr., marking an increase of 31.00 Cr..
• For Borrowings, as of Mar 2025, the value is 24.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 12.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 170.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 154.00 Cr. (Mar 2024) to 170.00 Cr., marking an increase of 16.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 728.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 669.00 Cr. (Mar 2024) to 728.00 Cr., marking an increase of 59.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 246.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2024) to 246.00 Cr., marking an increase of 22.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 69.00 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Mar 2024) to 69.00 Cr., marking an increase of 6.00 Cr..
• For Other Assets, as of Mar 2025, the value is 410.00 Cr.. The value appears strong and on an upward trend. It has increased from 370.00 Cr. (Mar 2024) to 410.00 Cr., marking an increase of 40.00 Cr..
• For Total Assets, as of Mar 2025, the value is 728.00 Cr.. The value appears strong and on an upward trend. It has increased from 669.00 Cr. (Mar 2024) to 728.00 Cr., marking an increase of 59.00 Cr..

Notably, the Reserves (510.00 Cr.) exceed the Borrowings (24.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Elin Electronics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.11. This value is within the healthy range. It has increased from 2.90 (Mar 24) to 6.11, marking an increase of 3.21.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.11. This value is within the healthy range. It has increased from 2.90 (Mar 24) to 6.11, marking an increase of 3.21.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.07. This value is within the healthy range. It has increased from 7.45 (Mar 24) to 11.07, marking an increase of 3.62.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 109.68. It has increased from 104.97 (Mar 24) to 109.68, marking an increase of 4.71.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 109.68. It has increased from 104.97 (Mar 24) to 109.68, marking an increase of 4.71.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 242.32. It has increased from 217.36 (Mar 24) to 242.32, marking an increase of 24.96.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.52. This value is within the healthy range. It has increased from 10.36 (Mar 24) to 14.52, marking an increase of 4.16.
• For PBIT / Share (Rs.), as of Mar 25, the value is 9.46. This value is within the healthy range. It has increased from 5.80 (Mar 24) to 9.46, marking an increase of 3.66.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.91. This value is within the healthy range. It has increased from 4.11 (Mar 24) to 7.91, marking an increase of 3.80.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.02. This value is within the healthy range. It has increased from 2.89 (Mar 24) to 6.02, marking an increase of 3.13.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.02. This value is within the healthy range. It has increased from 2.89 (Mar 24) to 6.02, marking an increase of 3.13.
• For PBDIT Margin (%), as of Mar 25, the value is 5.99. This value is below the healthy minimum of 10. It has increased from 4.76 (Mar 24) to 5.99, marking an increase of 1.23.
• For PBIT Margin (%), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 10. It has increased from 2.66 (Mar 24) to 3.90, marking an increase of 1.24.
• For PBT Margin (%), as of Mar 25, the value is 3.26. This value is below the healthy minimum of 10. It has increased from 1.88 (Mar 24) to 3.26, marking an increase of 1.38.
• For Net Profit Margin (%), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 5. It has increased from 1.33 (Mar 24) to 2.48, marking an increase of 1.15.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.48. This value is below the healthy minimum of 8. It has increased from 1.33 (Mar 24) to 2.48, marking an increase of 1.15.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.48. This value is below the healthy minimum of 15. It has increased from 2.75 (Mar 24) to 5.48, marking an increase of 2.73.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.41. This value is below the healthy minimum of 10. It has increased from 5.39 (Mar 24) to 8.41, marking an increase of 3.02.
• For Return On Assets (%), as of Mar 25, the value is 4.02. This value is below the healthy minimum of 5. It has increased from 2.07 (Mar 24) to 4.02, marking an increase of 1.95.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.69. It has increased from 1.48 (Mar 24) to 1.69, marking an increase of 0.21.
• For Current Ratio (X), as of Mar 25, the value is 2.61. This value is within the healthy range. It has decreased from 2.74 (Mar 24) to 2.61, marking a decrease of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 2.03 (Mar 24) to 1.90, marking a decrease of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.12. This value is within the healthy range. It has increased from 6.36 (Mar 24) to 7.12, marking an increase of 0.76.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 34.54 (Mar 24) to 0.00, marking a decrease of 34.54.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 13.41 (Mar 24) to 0.00, marking a decrease of 13.41.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 65.46 (Mar 24) to 0.00, marking a decrease of 65.46.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.59 (Mar 24) to 0.00, marking a decrease of 86.59.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.32. This value is within the healthy range. It has increased from 6.12 (Mar 24) to 9.32, marking an increase of 3.20.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.87. This value is within the healthy range. It has increased from 2.71 (Mar 24) to 4.87, marking an increase of 2.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 582.64. It has decreased from 615.19 (Mar 24) to 582.64, marking a decrease of 32.55.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has decreased from 0.59 (Mar 24) to 0.48, marking a decrease of 0.11.
• For EV / EBITDA (X), as of Mar 25, the value is 8.08. This value is within the healthy range. It has decreased from 12.39 (Mar 24) to 8.08, marking a decrease of 4.31.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.61 (Mar 24) to 0.49, marking a decrease of 0.12.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 65.45 (Mar 24) to 0.00, marking a decrease of 65.45.
• For Price / BV (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.27 (Mar 24) to 1.08, marking a decrease of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.61 (Mar 24) to 0.49, marking a decrease of 0.12.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.05, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness